BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33408168)

  • 1. CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach.
    Moritz CP; Tholance Y; Stoevesandt O; Ferraud K; Camdessanché JP; Antoine JC
    Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33408168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases.
    Moritz CP; Paul S; Stoevesandt O; Tholance Y; Camdessanché JP; Antoine JC
    Autoimmun Rev; 2020 Feb; 19(2):102450. PubMed ID: 31838165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
    Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A
    Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
    Miyaji K; Shahrizaila N; Umapathi T; Chan YC; Hirata K; Yuki N
    Hum Immunol; 2014 Nov; 75(11):1089-91. PubMed ID: 25286001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proper definition of the set of autoantibody-targeted antigens relies on appropriate reference group selection.
    Moritz CP; Stoevesandt O; Tholance Y; Camdessanché JP; Antoine JC
    N Biotechnol; 2021 Jan; 60():168-172. PubMed ID: 33045420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
    Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
    Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completing the Immunological Fingerprint by Refractory Proteins: Autoantibody Screening via an Improved Immunoblotting Technique.
    Moritz CP; Tholance Y; Rosier C; Reynaud-Federspiel E; Svahn J; Camdessanché JP; Antoine JC
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800157. PubMed ID: 30768763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
    Pascual-Goñi E; Fehmi J; Lleixà C; Martín-Aguilar L; Devaux J; Höftberger R; Delmont E; Doppler K; Sommer C; Radunovic A; Carvajal A; Smyth S; Williams L; Mazanec R; Potočková V; Hinds N; Cassereau J; Viala K; Lefilliatre M; Nicolas G; Foley P; Leypoldt F; Keddie S; Lunn MP; Zimprich F; Nunkoo VS; Löscher WN; Martínez-Martínez L; Díaz-Manera J; Rojas-Garcia R; Illa I; Rinaldi S; Querol L
    Brain; 2021 May; 144(4):1183-1196. PubMed ID: 33880507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
    Martinez-Martinez L; Lleixà MC; Boera-Carnicero G; Cortese A; Devaux J; Siles A; Rajabally Y; Martinez-Piñeiro A; Carvajal A; Pardo J; Delmont E; Attarian S; Diaz-Manera J; Callegari I; Marchioni E; Franciotta D; Benedetti L; Lauria G; de la Calle Martin O; Juárez C; Illa I; Querol L
    J Neuroinflammation; 2017 Nov; 14(1):224. PubMed ID: 29145880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
    Tang L; Huang Q; Qin Z; Tang X
    J Neurol; 2021 Aug; 268(8):2757-2768. PubMed ID: 32266541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
    Beppu M; Sawai S; Satoh M; Mori M; Kazami T; Misawa S; Shibuya K; Ishibashi M; Sogawa K; Kado S; Kodera Y; Nomura F; Kuwabara S
    J Neuroimmunol; 2015 Oct; 287():9-15. PubMed ID: 26439954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy.
    Yan WX; Archelos JJ; Hartung HP; Pollard JD
    Ann Neurol; 2001 Sep; 50(3):286-92. PubMed ID: 11558784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
    Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
    J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology.
    Caballero-Ávila M; Lleixà C; Pascual-Goñi E; Martín-Aguilar L; Vidal-Fernandez N; Tejada-Illa C; Collet-Vidiella R; Rojas-Garcia R; Cortés-Vicente E; Turon-Sans J; Gallardo E; Olivé M; Vesperinas A; Carbayo Á; Llansó L; Martinez-Martinez L; Shock A; Christodoulou L; Dizier B; Freeth J; Soden J; Dawson S; Querol L
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200216. PubMed ID: 38484217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcot-Marie-Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study.
    Hauw F; Fargeot G; Adams D; Attarian S; Cauquil C; Chanson JB; Créange A; Gendre T; Deiva K; Delmont E; Francou B; Genestet S; Kuntzer T; Latour P; Le Masson G; Magy L; Nardin C; Ochsner F; Sole G; Stojkovic T; Maisonobe T; Tard C; Van den Berghe P; Echaniz-Laguna A
    Eur J Neurol; 2021 Sep; 28(9):2846-2854. PubMed ID: 34060689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies.
    Bailly L; Mongin M; Delorme C; Apartis E; Saheb S; Viala K; Roze E
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():606. PubMed ID: 30619643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China.
    Zhang X; Zheng P; Devaux JJ; Wang Y; Liu C; Li J; Guo S; Song Y; Wang Q; Feng X; Wang Y
    J Neuroimmunol; 2019 Dec; 337():577074. PubMed ID: 31693967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
    Pascual-Goñi E; Martín-Aguilar L; Querol L
    Curr Opin Neurol; 2019 Oct; 32(5):651-657. PubMed ID: 31306213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy.
    Querol L; Nogales-Gadea G; Rojas-Garcia R; Martinez-Hernandez E; Diaz-Manera J; Suárez-Calvet X; Navas M; Araque J; Gallardo E; Illa I
    Ann Neurol; 2013 Mar; 73(3):370-80. PubMed ID: 23280477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.